Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-06-22
1996-06-18
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514912, A61K 3700
Patent
active
055277748
ABSTRACT:
This invention is for a method of treating cataracts in eyes by couching or dislocating of the cataractous lens. It includes the steps of introducing a zonulolysis-causing substance into the interior of the eye adjacent to the cataractous lens in sufficient quantity and strength to produce zonulolysis of the lens zonules normally holding the lens of the eye in place. The zonulolysis-causing substance is maintained in said eye adjacent the zonules until zonulolysis occurs and said lens moves into the inferior cavity of the eye. Alphachymotrypsin is one form of zonulolysis-causing substance. That substance may be introduced through a clear portion of the cornea into the anterior chamber of the eye without rupturing the lens capsule. A quantity of aqueous may be removed from the anterior chamber before introducing the zonulolysis-causing substance. That substance may also be introduced by injection of the substance through the pars plana into the vitreous behind the cataractous lens or by topical application in the presence of means to transport the substance to the lens zonules.
REFERENCES:
Kirby: The Early History of Cataract Surgery, SURGERY OF CATARACT 3-18, 1950.
Barraquer J.: Enzymatic Zonololysis, ACTA OPHTHALMOLOGICA 36:803-806, 1958.
Barraquer J.: Enzymatic Zonulolysis in Lens Extraction, ARCH OPHTHALMOL 66:6-11, 1961.
Sood N. N., Ratnaraj A.: Couching for Cataract, Hazards and Management, AM J OPTHALMOL 66:687-693, 1968.
Brandt F., Hennig A., Prasad L. N., Rai N. C., Upadhyay M. P.: Results of operative/couching of the lens (a study from Nepal), KLIN. MBL. AUGENHEILK 85:543-546, 1984.
Belyaev V. S., and Barachlov, V. I.: A Modern Experience with Couching for Catarcat, ANNALS OF OPTHALMOLOGY 14:742-745, 1982.
Chandler P. A.: Choice of Treatment in Dislocation of the Lens, ARCH OPHTHALMOL 71:765-786, 1964.
Grant W. M.: Chymotrypsin. Toxicology of the Eye, Springfield; Charles C. Thomas 1986; 235-239.
Article by Dr. Girard in Ocular Surgery News, Feb. 2, 1993.
LandOfFree
Dislocation of cataractous lens by enzymatic zonulolysis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dislocation of cataractous lens by enzymatic zonulolysis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dislocation of cataractous lens by enzymatic zonulolysis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-222901